Development of control serum for microbial antibody tests

Biologicals

Volumn 29, Issue 1, 2001, Pages 39-43

  Uemura, Yahiro ^a   Baba, Toshiyuki ^a   Hasegawa, Yuzo ^a   Yanagihara, Osamu ^a   Matsumoto, Katsuhito ^a   Kawai, Tadashi ^a  

^a International Reagents Corporation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ARTICLE; CLINICAL CHEMISTRY; CONTROL SYSTEM; DEVICE; IMMUNOASSAY; PRIORITY JOURNAL; TREPONEMA PALLIDUM HEMAGGLUTINATION TEST; VIRUS INACTIVATION;

EID: 0034909206     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.2001.0274     Document Type: Article

References (26)

1. Inactivation and elimination of viruses in the manufacturing process of human serum albumin
2. Inactivation and elimination of viruses during the fractionation of an intravenous immunoglobulin preparation. Liquid heat treatment and polyethyleneglycol fractionation
3. Inactivation and elimination of viruses during preparation of human intravenous immunoglobulin
4. Studies of heat-treated intravenous immunoglobulin preparation
5. Inactivation and elimination of viruses during preparation of Antithrombin-III
6. Virus validation test in the manufacturing process of Antithrombin-III
7. Inactivation and elimination of viruses in the manufacturing process of human haptoglobin
8. Inactivation and elimination of viruses in the manufacturing process of ulinastatin preparation
9. Chemical, clinical and immunological studies on the products of human plasma fractions
10. Disinfection and inactivation of the human T lymphotropic virus type III/lymphadenopathy-associated virus
11. Enhancement in the safety of immunoglobulins prepared from high-risk plasma
12. Inactivation of viruses in labile blood derivatives I. Disruption of lipid-enveloped viruses by tri-(n-butyl) phosphate detergent combinations
13. Solvent/detergent-treated plasma. A virus-inactivated substitute for fresh frozen plasma
14. Elimination of virus from a coagulation factor IX product
15. Viral safety of solvent-detergent treated blood products. Virological safety aspects of plasma derivatives
16. Severe heat treatment of freeze-dried coagulation factor concentrates. Is hotter necessarily better?
17. Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light
18. Insufficient inactivation of HIV-1 in human cryo poor plasma by betapropiolactone. Results from a highly accurate virus detection method
19. Acute HIV-1 infection in patients with hemophilia B treated with β-propiolactone-UV-inactivated clotting factor
20. HIV inactivation test in the manufacturing process of fibrinogen
21. Inactivation of human immunodeficiency virus by gamma radiation and its effect on plasma and coagulation factors
22. Inactivation effect and stability of viruses of RCG-5
23. Iodine-mediated inactivation of lipid and nonlipid-enveloped viruses in human antithrombin III concentrate
24. Inactivation of viruses in blood with aluminum phthalocyanine derivatives
25. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light
26. Psoralen-mediated photodecontamination of platelet concentrate: Inactivation of cell-free and cell-associated forms of human immunodeficiency virus and assessment of platelet function in vivo